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Infection of Mammalian Hepatocytes by Francisella tularensis 
Monique van Hoek, Debra Anderson, Anne Pingitore, 
Pavel Vasioutovitch, Megan Schaffner, Koryn Johnston, Allison Jablonski 
 
Abstract  
Francisella tularensis, the causative agent of Tularemia, is a facultative intracellular parasite. The goal of this 
project is to examine how F. tularensis infects and replicates within mammalian cells, and the impact of such 
an infection upon the signaling pathways within the host cell. The murine embryonic hepatocyte cell line TIB-
73 serves as our model system for infection by F. tularensis live vaccine strain (LVS). The number of bacteria 
associated with hepatocytes was quantified via adhesion, invasion and intracellular replication assays. We 
have determined that a large multiplicity of infection (MOI) of F. tularensis LVS is required to infect the 
hepatocyte cells. The infective capacity of F. tularensis LVS in hepatocytes was found to be ineffective below 
an MOI of 0.1. Western blotting was used to determine the presence of various kinases in hepatocytes before 
infection with F. tularensis LVS.  
 
Introduction 
Francisella tularensis, the causative agent of tularemia, is a naturally occurring disease of rabbits that causes 
disease in humans through accidental contact with bacteria via infected material or insect vectors (1). 
Tularemia is considered to be a likely agent for use in a bioweapons attack and is a Category A biothreat agent 
(along with smallpox, plague and anthrax), due to its high infectivity when released as an aerosol (3, 5). 
Aerosolized F. tularensis has an ID50 with the inhalation of as few as 10 bacteria (1, 7). F. tularensis live 
vaccine strain (LVS) is a useful laboratory model for understanding the infectious process of this organism as 
it is generally considered avirulent for humans, but can be lethal to mice and rats (2, 4).  
F. tularensis is a facultative intracellular pathogen known to infect and multiply inside macrophages (4, 5, 10). 
Once it is established in the cells of the host, F. tularensis replicates, disseminates and continues the infection 
(5). 
In lethal cases of tularemia in mice, pathological deterioration of the spleen and more notably the liver has 
been observed (5). Histological studies of livers from infected mice demonstrate extensive necrosis and 
bacteria-laden hepatocytes (6).  
Our hypothesis is that one cause of pathogenesis of tularemia is that F. tularensis LVS attacks and infects 
causing failure of the liver, although the mechanism by which this is accomplished has not yet been identified.  
Based on many published reports of liver pathology and bacterial burden during Francisella infection, we 
propose to examine the ability of hepatocytes to be infected. There are multiple cell types within the liver, 
including Kupffer cells, stellate cells and hepatocytes (8). In order to examine hepatocyes in isolation, we have 
used a murine embryonic cell line, TIB-73. TIB-73 hepatocyte cells have been proven to be a useful non-
phagocytic cell infection model for the study of Salmonella typhimurium infection (9).   
To better understand the consequences of infection of mammalian cells by F. tularensis LVS, we will examine 
activation of several important and shared protein phosphorylation pathways. This will help to elucidate the 
disease process and may reveal new drug targets for novel treatments.  
The purpose of this study was to demonstrate that F. tularensis LVS is able to adhere to, invade and replicate 
within hepatocyte cells and to establish the presence of important kinases in hepatocytes . This work sets the 
stage for our future studies. 
 
Materials and Methods 
Bacterial strains and growth conditions. F. tularensis LVS was obtained from the American Type Culture 
Collection (Manassas, VA). Bacteria were grown in TSB-C (Trypticase Soy Broth, supplemented with 0.1% 
cysteine HCl). 
Tissue culture cells. All experiments were carried out using murine embryonic TIB-73 hepatocyte cells 
(ATCC, BNL.CL.2). Cells were cultured in T-25 flasks and maintained in Dulbecco’s modified Eagle medium 
(DMEM), supplemented with 10% Fetal Bovine Serum (FBS).  
Adhesion Assay. Hepatocytes were grown to confluency and trypsinized with 5% Trypsin-EDTA. The cells 
were counted using a hemocytometer, added to a flat bottom 96-well tissue culture plate to yield 
approximately 1x105 cells per well, and were allowed to adhere overnight. An overnight culture 
(approximately 18 hours) of F. tularensis LVS was grown to an OD600 of about 0.6 yielding approximately 
1x109 CFU/ml and was diluted to approximately 1x108 CFU/ml in TSB-C (an aliquot was removed for CFU 
determination by colony counting).  Tissue culture wells were washed twice with fresh DMEM and 100μl of 
DMEM was placed in each well. A bacterial inoculum with a multiplicity of infection (MOI) of 100 
(approximately 100 μl of 1x108 CFU/ml) was added to each experimental well; TSB-C was added to each 
negative control well. The plate was centrifuged for 5 min at 500 g to encourage contact of bacterial cells with 
hepatocytes. Infected cells were incubated at 37ºC in 5% CO2. At various time intervals, cells were washed 
three times with fresh DMEM to remove free bacteria. Cells were lysed in 200 μl of sterile deionized water 
followed by vigorous pipetting. Serial dilutions of collected lysate were performed (using sterile deionized 
water), plated onto Columbia Blood Agar supplemented with 5% defibrinated horse blood (CBA-H 5%), 
incubated at 37ºC and counted after a 72 hour growth period.   
Invasion Assay. To determine the number of invading bacteria, a hepatocyte monolayer was infected with 
bacterial inocula (as above) and incubated for 120 min. Cells were washed 3 times with DMEM and 
gentamicin sulfate was added to each experimental well at a concentration of 20 μg/ml in DMEM for 10 min. 
Then, cells were washed 3 times with DMEM to remove excess gentamicin. Cells were lysed and processed 
(as above). 
Intracellular replication of F. tularensis LVS in hepatocytes. To study intracellular growth, a replication 
assay was performed at the same time and set up in the same manner as the invasion assay. After treating 
infected cells with 20 μg/ml of gentamicin, cells were washed three times with fresh DMEM. The cells were 
incubated at 37ºC in 5% CO2 for a total of 48 hours. Cells were lysed and processed (as above) at various time 
intervals. 
Antibodies.  Antibodies to kinase molecules that were used in this study include: Mouse monoclonal:  IRAK-
1 (Santa Cruz Biotechnology #sc-5288, directed to amino acids 440-712).  Rabbit polyclonals:  p38 MAP 
Kinase (Cell Signaling Technology #9212); p65 NFκB (Cell Signaling Technology #3034); MEK1/2 (Cell 
Signaling Technology #9122); IKKα (Cell Signaling Technology #2682); NIK (Santa Cruz Biotechnology 
#7211).  
 
Western immunoblotting.  TIB-73 hepatocyte cells were lysed in RIPA detergent buffer (10mM Tris-HCl pH 
7.2, 1% Triton-X, 0.5% sodium deoxycholate, 150mM NaCl, 1mM EDTA, 1mM sodium orthovanadate, 50 
µg/ml leupeptin and 0.5% aprotinin).  All procedures were performed at 4-100C.  Lysates were cleared by 
centrifugation for 15 min at 15,000 x g in a microcentrifuge, and protein concentration was determined by 
BioRad protein reagent.  Samples were diluted in 2X sample buffer (125mM Tris-HCl, 4% SDS, 10% 
glycerol, 0.02% bromophenol blue, 4% β-mercaptoethanol) and boiled for 5 min.  Lysate proteins were 
separated by electrophoresis through a 7.5% SDS-polyacrylamide gel and transferred to Immobilon-P 
membranes (Millipore, Bedford, MA). (50 µg whole-cell lysate was assayed per lane.)  Membranes were 
blocked with either 5% non-fat dry milk or 3% bovine serum albumin in Tris-buffered saline + Tween solution 
for 1 hour-overnight, and incubated with primary antibody over night at 4ºC.  Binding of primary antibodies 
was visualized by enhanced chemiluminescence (ECL) (Amersham, Buckinghamshire, England), using Kodak 
BioMax Light Film. 
 
Immunofluorescence Antibodies.  Antibodies to F. tularensis used in this study include: Mouse monoclonal:  
anti-Francisella LPS antibody, blend of FB11 and T14 (Chemicon International #MAB8267).From the 
manufacturer: Antibody “isotype: IgG2a (FB11) and IgG3 (T14). Clones FB11 and T14 were derived from 
hybridization of Sp2/0 myeloma cells with spleen.” Specificity: This antibody “recognizes LPS of virulent and 
vaccine strains of F. tularensis. There is no cross-reactivity with: F. novicida, Br. abortus, Br. suis, Br. 
melitensis, Br. ovis, Y. pestis, Y. entercolitica, Y. pseudotuberculosis, E. coli, V. cholerae.  The binding site for 
clone FB11 is located on the O-antigen polysaccharide chain”. Secondary polyclonal:  FITC anti-mouse IgG 
(H+L) (Biomeda #F63). 
 Immunofluorescence. TIB-73 cells were plated in a slide chamber at a cell concentration of 5 x 105 cells per 
chamber. The cells were allowed to adhere overnight and were infected with F. tularensis LVS at an MOI of 
100 and incubated at 37ºC in 5% CO2 for 12 hours. The cells were then washed with 4ºC phosphate buffered 
saline (PBS), fixed in a 2% Paraformaldehyde (PFA) fixative (4% PFA, 3x PBS, 2N NaOH). The cells were 
treated with a 10% bovine serum album (BSA) blocking buffer (10% BSA, 1x PBS, 0.3% Triton X-100) for 
20 min. Cells were incubated with primary anti-Francisella LPS antibody (5 µg/ml) for 60 min at room 
temperature. Cells were washed and incubated with secondary anti-mouse antibody with fluorescein (1 µg/ml) 
for 45 min. Binding of antibodies was visualized by fluorescence microscopy, Canon digital camera and 
Adobe Photoshop 6.0.  
Results 
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Figure 1: Adhesion assay demonstrating optimal MOI of F. tularensis in TIB-73 hepatocytes.  Increasing 
amounts of bacteria were added to 1 x 105 TIB-73 cells for 1 hour.  Data are expressed as mean +/- standard 
error mean (SEM). 
Average load of adhering F. tularensis  LVS bacteria to TIB 73 cells
0
0.005
0.01
0.015
0.02
0.025
0.03
0.035
0.04
0 30 60 90 120
Time (min) 
Ba
ct
er
ia
 R
ec
ov
er
ed
/T
IB
-7
3 
ce
ll
Data set 1: Avg cfu/ml*
Data set 2: Avg cfu/ml
*Data from single point  
Figure 2: Adhesion assay demonstrating optimal incubation times at an MOI of 100.  Data shown are from 
two separate data sets, but the number of bacteria per cell is consistent between trials. The number of adhering 
bacteria increased over time and yielded 0.035 bacteria per TIB-73 cell.  
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Figure 3: Adhesion assay demonstrating optimal MOI to 1000 MOI. An increasing number of bacteria were 
recovered with an increase in MOI inoculum.  
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Figure 4: Intracellular replication assay demonstrating increasing amounts of recovered bacteria following 
TIB-73 infection.  
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Figure 5.  Relative abundance by Western Blotting of various kinases believed to be active in the TLR 
signaling pathway in hepatocytes. 
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Figure 6:  Light Microscopy of Uninfected and Infected TIB-73 cells.  TIB-73 cells were examined under 
40X light microscopy.  Panel (A) represents uninfected cells.  Panel (B) are cells infected for 12 hours, 
illustrating some cytopathic effects. 
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Figure 7:  Immunofluorescence of Francisella tularensis LVS infected TIB-73 cells. TIB-73 cells were 
examined under 100X light and fluorescence microscopy. Panel (A) shows immuno-fluorescence image with 
bright small dots representing bacteria. Primary: anti-Francisella LPS Mouse monoclonal antibody, Blend of 
FB11 and T14. Secondary: FITC anti-mouse IgG Polyclonal.  Panel (B) is the same field under light 
microscopy illustrating the TIB-73 cells.  Panel (C) shows an overlay of the images and bacteria are seen to be 
associated with the margins of the TIB-73 cells. 
 
 
Conclusions  
We present evidence to support our hypothesis that F. tularensis is able to effectively adhere, invade, and 
multiply within hepatocyte cells. Our data is consistent with other studies of intracellular pathogens such as S. 
typhimurium (9), which are able to adhere, invade and replicate within non-phagocytic hepatocyte cells, as 
well as with studies of Francisella replication in macrophages (10).  
At an MOI of 100 about 0.003 bacteria adhered per TIB-73 cell after 60 minutes of incubation. Lajarin et. al. 
demonstrated that S. typhimurium infected TIB-73 cells with a maximum of 15 cell-associated bacteria per 
cell and an invasion capacity of 0.003 bacteria per hepatocyte. The number of adhering bacteria increased 10 
fold following an additional 60 minutes of incubation.  
Golovliov et. al. used an MOI of 200 to produce 1.7 bacteria per macrophage (11) and is thought to be 
correlated to hepatocytes as well. An MOI of 500 has been used to infect macrophages but has not 
demonstrated a linear relationship between MOI and the number of bacteria per macrophage (12).  
Hepatocytes have been found to be comparably susceptible to infection by Francisella with respect to 
macrophage infection. It is unclear where in the liver invasion occurs, but our aim is to investigate whether 
pathogenesis occurs in hepatocyte cells.  
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